Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$4.14B |
| 2 |
Gilead Sciences
GILD
|
$990M |
| 3 |
CME Group
CME
|
$963M |
| 4 |
Broadcom
AVGO
|
$890M |
| 5 |
TE Connectivity
TEL
|
$720M |
Top Sells
| 1 |
CSX Corp
CSX
|
$2.52B |
| 2 |
Wells Fargo
WFC
|
$2.39B |
| 3 |
Amgen
AMGN
|
$2.39B |
| 4 |
Illumina
ILMN
|
$1.72B |
| 5 |
AbbVie
ABBV
|
$1.67B |
Sector Composition
| 1 | Healthcare | 21.59% |
| 2 | Technology | 15.06% |
| 3 | Communication Services | 14.35% |
| 4 | Consumer Discretionary | 13.12% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Qualcomm
QCOM
$173B
| $3.18B | 0.93% | 44,210,204 -9,934,932 | -18% | -$716M |
|
27
Accenture
ACN
$162B
| $3.04B | 0.88% | 17,858,633 -8,244,049 | -32% | -$1.4B |
|
|
28
CSX Corp
CSX
$60.6B
| $2.93B | 0.85% | 39,576,003 -34,092,480 | -46% | -$2.52B |
|
|
29
Illumina
ILMN
$15.8B
| $2.89B | 0.84% | 7,868,159 -4,692,864 | -37% | -$1.72B |
|
|
CXO
30
DELISTED
CONCHO RESOURCES INC.
CXO
| $2.87B | 0.83% | 18,785,086 +1,416,319 | +8% | +$216M |
|
31
Coca-Cola
KO
$297B
| $2.8B | 0.81% | 60,625,900 -8,305,002 | -12% | -$384M |
|
32
Stryker
SYK
$150B
| $2.58B | 0.75% | 14,533,858 -9,014,729 | -38% | -$1.6B |
|
33
Costco
COST
$418B
| $2.57B | 0.75% | 10,943,778 -1,055,673 | -9% | -$248M |
|
34
Teva Pharmaceuticals
TEVA
$21.1B
| $2.56B | 0.74% | 118,848,600 -3,184,236 | -3% | -$68.6M |
|
35
Vale
VALE
$43.9B
| $2.48B | 0.72% | 166,949,068 -38,704,769 | -19% | -$574M |
|
36
Lockheed Martin
LMT
$106B
| $2.47B | 0.72% | 7,145,676 -719,901 | -9% | -$249M |
|
37
Marriott International Class A Common Stock
MAR
$72.7B
| $2.46B | 0.71% | 18,626,031 +3,997,729 | +27% | +$528M |
|
38
American International
AIG
$45.1B
| $2.37B | 0.69% | 44,500,728 -10,553,911 | -19% | -$562M |
|
39
Booking.com
BKNG
$181B
| $2.29B | 0.67% | 1,153,799 +69,748 | +6% | +$138M |
|
40
Canadian Natural Resources
CNQ
$65.9B
| $2.22B | 0.65% | 68,040,368 -18,658,602 | -22% | -$610M |
|
41
Texas Instruments
TXN
$184B
| $2.14B | 0.62% | 19,959,025 -8,300,656 | -29% | -$891M |
|
42
McDonald's
MCD
$224B
| $1.91B | 0.55% | 11,402,746 -67,074 | -0.6% | -$11.2M |
|
43
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.9B | 0.55% | 19,549,133 -2,043,999 | -9% | -$198M |
|
|
PARA
44
DELISTED
Paramount Global Class B
PARA
| $1.88B | 0.55% | 32,802,753 +7,877,689 | +32% | +$453M |
|
|
45
CME Group
CME
$96B
| $1.86B | 0.54% | 10,906,683 +5,658,108 | +108% | +$963M |
|
|
NBL
46
DELISTED
Noble Energy, Inc.
NBL
| $1.76B | 0.51% | 56,350,053 -4,061,264 | -7% | -$127M |
|
47
JPMorgan Chase
JPM
$829B
| $1.74B | 0.51% | 15,419,249 -6,321,556 | -29% | -$713M |
|
|
48
Wells Fargo
WFC
$263B
| $1.72B | 0.5% | 32,637,980 -45,463,282 | -58% | -$2.39B |
|
49
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.69B | 0.49% | 7,893,003 -2,850,817 | -27% | -$610M |
|
50
Dominion Energy
D
$51.1B
| $1.6B | 0.47% | 22,791,796 -2,580,926 | -10% | -$181M |
|